{"id":"W4397007666","doi":"10.1016/j.esmoop.2024.103102","title":"114P Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection (PH FDC SC) plus chemotherapy in HER2-positive early breast cancer (EBC): Long-term efficacy and safety analysis of the randomised, open-label, multicentre phase III (neo)adjuvant FeDeriCa study","year":2024,"lang":"en","type":"article","venue":"ESMO Open","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Pertuzumab; Trastuzumab; Medicine; Oncology; Chemotherapy; Fixed-dose combination; Breast cancer; Pharmacology; Internal medicine; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009870538,0.0006256075,0.001451845,0.0005329304,0.0001806412,0.0005186133,0.0007288848,0.0007096113,0.002355211],"category_scores_gemma":[0.0007281663,0.0003375945,0.0007723855,0.0004012074,0.0005930756,0.0003974104,0.0003681525,0.001472804,0.0005838851],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006342155,"about_ca_system_score_gemma":0.0005903539,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006527549,"about_ca_topic_score_gemma":0.001272047,"domain_scores_codex":[0.9995983,0.0002046222,0.00002633348,0.00004804603,0.00005594364,0.000066825],"domain_scores_gemma":[0.9997249,0.00006052711,0.00006740102,0.00003683552,0.00001828656,0.00009201081],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7686015,0.03414644,0.004126914,0.0008403429,0.00126019,0.0001758626,0.00008566308,0.002552314,0.03084852,0.0002547923,0.002559185,0.1545483],"study_design_scores_gemma":[0.4901643,0.4942768,0.008917351,0.00003226329,0.0005166111,0.0001788949,0.00001739001,0.0009333257,0.002743396,0.0001117783,0.002085678,0.00002229724],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945598,0.00154773,0.0005884346,0.0001721791,0.0001167679,0.001215704,0.0004118042,0.00007077643,0.001316766],"genre_scores_gemma":[0.9937282,0.001012236,0.001087104,0.0003174802,0.000135487,0.001159813,0.0008435571,0.00001454215,0.001701616],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002355211,"threshold_uncertainty_score":0.007878959,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01416510392552033,"score_gpt":0.3308973171457195,"score_spread":0.3167322132201991,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}